GSK malaria vaccine 257049 Vaccine

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

GSK malaria vaccine 257049 Vaccine
Treatment and conditionWhere it standsTrials
GSK malaria vaccine 257049 Vaccine for malariaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1